Announcements
- Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
- Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
- Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
- Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting
Key statistics
On Friday, Gyre Therapeutics Inc (L9S:STU) closed at 13.80, -10.97% below its 52-week high of 15.50, set on Apr 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.80 |
---|---|
High | 13.80 |
Low | 13.80 |
Bid | 12.80 |
Offer | 13.50 |
Previous close | 14.00 |
Average volume | 0.00 |
---|---|
Shares outstanding | 85.47m |
Free float | 15.58m |
P/E (TTM) | -- |
Market cap | 1.22bn USD |
EPS (TTM) | -20.60 USD |
Data delayed at least 15 minutes, as of May 17 2024.
More ▼